Skip to main content
Colin Dinney, MD, Urology, Houston, TX

ColinP.DinneyMD

Urology Houston, TX

Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center Distinguished Chair in Urology, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Chairman, Department o

Are you Dr. Dinney?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 43 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161

Summary

  • Dr. Colin Dinney, MD is a urologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor at Division of Surgery.

Education & Training

  • University of Manitoba
    University of ManitobaClass of 1982

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 1991 - 2026
  • OK State Medical License
    OK State Medical License 2020 - 2021

Awards, Honors, & Recognition

  • Top Doctors:SE Texas Castle Connolly, 2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Β-arrestins Regulate Stem Cell-like Phenotype and Response to Chemotherapy in Bladder Cancer
    Β-arrestins Regulate Stem Cell-like Phenotype and Response to Chemotherapy in Bladder CancerFebruary 20th, 2020
  • Ferring + Blackstone Life Sciences Launch New Oncology Company to Further Treatment for Invasive Bladder Cancer
    Ferring + Blackstone Life Sciences Launch New Oncology Company to Further Treatment for Invasive Bladder CancerNovember 25th, 2019
  • One of the World’s Largest Private Equity Firms Enters Targets Unmet Need for Bladder Cancer with Swiss Pharma
    One of the World’s Largest Private Equity Firms Enters Targets Unmet Need for Bladder Cancer with Swiss PharmaNovember 25th, 2019
  • Join now to see all

Grant Support

  • Developmental Research ProgramNational Cancer Institute2008–2010
  • Career Developement ProgramNational Cancer Institute2008–2010
  • Administrative CoreNational Cancer Institute2008–2010
  • Spore In Genitourinary CancerNational Cancer Institute2006–2010
  • M. D. Anderson Cancer Spore In Genitourinary CancersNational Cancer Institute2001–2005
  • Biology Of Bladder Cancer MetastasesNational Cancer Institute1996–2000

Professional Memberships